BEIJING--November 22, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--At present, China's domestic human growth hormone (hGH) mainly includes water and powder injections. Aqueous injection formulations have certain advantages in terms of drug activity and stability, and they are the main variety on the market. IIR is now tracking 42 active injections projects in China, worth US$3.15 billion.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!
